On July 6th, according to a statement from investment Q&A platform, Jingjia Corporation expressed that "due to the National Tobacco Monopoly Bureau launching a special inspection to regulate the e-cigarette market and crack down on illegal sales of non-standard cigarettes, combined with inventory depletion in the previous period, sales of national-standard e-cigarettes are expected to rebound.
The following is the original transcript of the Q&A:
Question: Secretary Dong, what is the current demand for e-cigarettes in the domestic and international markets?
In response, the company stated, "Hello, thank you for your interest in our company! In 2022, the global e-cigarette market witnessed a surge in growth, reaching sales of $23.65 billion, with a year-on-year increase of 20.0%. According to Sullivan's expectations, global e-cigarette sales are projected to maintain a compound annual growth rate of 18.5% from 2022 to 2027. In the domestic market, the National Tobacco Monopoly Administration has carried out special inspections to regulate the e-cigarette market and address illegal sales of non-standard cigarettes, in addition to clearing previous inventory. As a result, the sales of national standard e-cigarettes are expected to recover.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
